Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian Prindle

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Communications|August 2, 2020
Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositolYue Fu, David Estoppey, Silvio Roggo, et al.
Nature Communications|July 9, 2020
Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositolYue Fu, David Estoppey, Silvio Roggo, et al.
Nature Chemical Biology|October 20, 2015
Dark chemical matter as a promising starting point for drug lead discoveryAnne Mai Wassermann, Eugen Lounkine, Dominic Hoepfner, et al.
Nature|February 5, 2025
Synthetic lethality of mRNA quality control complexes in cancerVivian Prindle, Adam E Richardson, Kimberly R Sher, et al.
Nature Communications|October 13, 2015
FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26pStephen B Helliwell, Shantanu Karkare, Marc Bergdoll, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Communications|August 2, 2020
Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositolYue Fu, David Estoppey, Silvio Roggo, et al.
Nature Communications|July 9, 2020
Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositolYue Fu, David Estoppey, Silvio Roggo, et al.
Nature Chemical Biology|October 20, 2015
Dark chemical matter as a promising starting point for drug lead discoveryAnne Mai Wassermann, Eugen Lounkine, Dominic Hoepfner, et al.
Nature|February 5, 2025
Synthetic lethality of mRNA quality control complexes in cancerVivian Prindle, Adam E Richardson, Kimberly R Sher, et al.
Nature Communications|October 13, 2015
FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26pStephen B Helliwell, Shantanu Karkare, Marc Bergdoll, et al.
Pageof 1